Community-Led Recovery Initiatives Funding in the Marshall Islands
GrantID: 20509
Grant Funding Amount Low: $1,000,000
Deadline: July 29, 2022
Grant Amount High: $1,000,000
Summary
Explore related grant categories to find additional funding opportunities aligned with this program:
Black, Indigenous, People of Color grants, Community Development & Services grants, Disabilities grants, Domestic Violence grants, Education grants, Elementary Education grants.
Grant Overview
Capacity Constraints Facing Marshall Islands Applicants for RCORP-MAT Funding
The Rural Communities Opioid Response Program – Medication Assisted Treatment Access (RCORP-MAT) targets substance use disorder (SUD) reduction, including opioid use disorder (OUD), through medication-assisted treatment (MAT) expansion in rural settings. In the Marshall Islands, a nation of 29 coral atolls scattered across 750,000 square miles of Pacific Ocean, applicants confront profound capacity constraints that hinder effective grant utilization. These gaps manifest in infrastructure deficits, personnel shortages, and logistical barriers, distinct from mainland rural areas like those in Wisconsin, where denser road networks and larger facilities enable faster scaling.
The Ministry of Health and Human Services (MOHHS) oversees public health delivery but operates with minimal resources. Majuro Atoll hosts the primary hospital, Ebeye Hospital serves Kwajalein, and outer atolls rely on dispensaries. This fragmented system struggles to support MAT protocols requiring buprenorphine, methadone, or naltrexone administration, monitoring, and counseling. Applicants, often small non-profits in health and medical sectors, must bridge these voids without existing cold-chain storage for medications across remote islands, where power outages are routine due to diesel generator dependence.
Readiness assessments reveal that MOHHS facilities lack electronic health records or telehealth infrastructure calibrated for MAT adherence tracking. In contrast to Wisconsin's rural clinics with integrated behavioral health wings, Marshall Islands providers handle SUD cases amid competing priorities like tuberculosis and non-communicable diseases. Grant funds could address these, but baseline capacity limits rapid implementation, as initial site visits confirm no dedicated MAT clinics exist outside Majuro.
Workforce Shortages Impeding MAT Delivery
A critical resource gap lies in trained personnel. The Marshall Islands has fewer than 20 physicians for 59,000 residents, with most foreign-trained expatriates rotating through short-term contracts. MOHHS reports no certified MAT prescribers under the Drug Addiction Treatment Act (DATA 2000) waivers, essential for buprenorphine initiation. Nurses and counselors, vital for MAT's psychosocial components, number under 100 island-wide, many untrained in evidence-based therapies like contingency management tailored to SUD.
Non-profits targeting individual or small business operators in affected communities face recruitment hurdles. High turnover stems from isolation; professionals from denser regions like Guam depart quickly. Training pipelines are nascent; the College of the Marshall Islands offers basic nursing but no SUD specialization. Applicants must invest grant dollars in DATA waiver programs or partnerships with Pacific Basin entities, yet travel for off-island certification delays rollout by months. This contrasts sharply with Wisconsin, where rural workforce incentives retain providers longer.
Outer atoll readiness is negligible. Inter-island flights via Air Marshall Islands operate sporadically, stranding MAT teams during fuel shortages or weather disruptions common in this vast ocean expanse. Dispensary staff, often local aides with high school education, cannot manage partial agonist dosing without supervision, amplifying diversion risks in cash-based economies.
Logistical and Supply Barriers in Dispersed Atoll Settings
Supply chain frailties exacerbate gaps. Pharmaceuticals enter via U.S. Postal Service or cargo ships to Majuro, then boat to outer islands, risking expiration in humid conditions without refrigerated transport. MOHHS procurement aligns with Compact of Free Association aid cycles, creating mismatches with RCORP-MAT's quarterly reporting. Applicants in health and medical non-profits must navigate FDA import rules for controlled substances, complicated by no bonded warehouses.
Data systems are rudimentary; paper charts dominate, impeding SAMHSA-required outcome metrics like retention rates. Grant workflows demand baseline SUD prevalence mapping, but MOHHS surveillance captures only hospital admissions, missing community-level OUD hidden by stigma or alternative substances. Other interests like small businesses supplying pharmacies encounter zoning issues for secure storage, absent in atoll villages.
Funding at $1 million cap strains multi-year MAT scaling across atolls. Phase 1 planning grants might suit initial assessments, but full implementation requires vessels for mobile MAT units, unavailable locally. Compared to Wisconsin's truck-based outreach, boat-dependent models here double costs. Compliance with HRSA site visits poses risks; inspectors from Honolulu face typhoon-season delays.
These constraints demand phased applications: first fortify Majuro as a hub, then extend via trained navigators. Non-profits must audit gaps via MOHHS collaboration, prioritizing MAT inductions over full networks initially. Resource mapping reveals 70% of needs unmet in outer islands, per regional Pacific health forums.
Q: What are the main workforce gaps for MAT in the Marshall Islands? A: Lack of DATA-waivered prescribers and trained counselors, with under 20 physicians total, requires grant-funded training and retention incentives beyond MOHHS capacity.
Q: How do supply chain issues affect RCORP-MAT in outer atolls? A: Intermittent shipping and no cold storage lead to medication spoilage; applicants need funds for dedicated boats and generators.
Q: Can small business non-profits address Marshall Islands capacity shortfalls? A: Yes, but they face zoning and import barriers; partner with MOHHS for pharmacy securement before MAT expansion.
Eligible Regions
Interests
Eligible Requirements
Related Grants
Data, Science and Technology Grant
The Fund invests in ideas and organizations that leverage data, science, and technology to supp...
TGP Grant ID:
20551
Neuroscience Prize
The Prize recognizes an outstanding discovery or significant advance in the field of neuroscience. T...
TGP Grant ID:
20568
Grants to USA, Canada, and International individuals for Research and Education in Aquatic Life
Grants to USA, Canada, and international individuals for research and education projects with a...
TGP Grant ID:
20571
Data, Science and Technology Grant
Deadline :
2022-08-15
Funding Amount:
$0
The Fund invests in ideas and organizations that leverage data, science, and technology to support people in poverty in the navigation of economi...
TGP Grant ID:
20551
Neuroscience Prize
Deadline :
2099-12-31
Funding Amount:
$0
The Prize recognizes an outstanding discovery or significant advance in the field of neuroscience. The prize is...
TGP Grant ID:
20568
Grants to USA, Canada, and International individuals for Research and Education in Aquatic Life
Deadline :
2024-01-15
Funding Amount:
$0
Grants to USA, Canada, and international individuals for research and education projects with a focus on aquatic life.
TGP Grant ID:
20571